The study aimed to describe the epidemiology and outcomes of hospital-acquired bloodstream infections (HABSIs) between COVID-19 and non-COVID-19 critically ill patients.
Buetti, N., Tabah, A., Loiodice, A., Ruckly, S., Aslan, A.T., Montrucchio, G., et al. (2022). Different epidemiology of bloodstream infections in COVID-19 compared to non-COVID-19 critically ill patients: a descriptive analysis of the Eurobact II study. CRITICAL CARE, 26(1) [10.1186/s13054-022-04166-y].
Different epidemiology of bloodstream infections in COVID-19 compared to non-COVID-19 critically ill patients: a descriptive analysis of the Eurobact II study
Cortegiani, Andrea;
2022-01-01
Abstract
The study aimed to describe the epidemiology and outcomes of hospital-acquired bloodstream infections (HABSIs) between COVID-19 and non-COVID-19 critically ill patients.
File in questo prodotto:
| File | Dimensione | Formato | |
|---|---|---|---|
|
s13054-022-04166-y.pdf
Solo gestori archvio
Tipologia:
Versione Editoriale
Dimensione
1.4 MB
Formato
Adobe PDF
|
1.4 MB | Adobe PDF | Visualizza/Apri Richiedi una copia |
I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.
